Literature DB >> 3516082

Effects of estradiol and some antiestrogens (clomiphene, tamoxifen, and hydroxytamoxifen) on luteinizing hormone secretion by rat pituitary cells in culture.

G Emons, O Ortmann, S Thiessen, R Knuppen.   

Abstract

Primary pituitary cell cultures from adult female rats were incubated for 4 or 24 h with various concentrations of estradiol (E2) or the antiestrogens (AE) tamoxifen (TMX), 4-hydroxytamoxifen (OH-TMX), and clomiphene citrate (CC). The luteinizing hormone (LH)-response of these cultures to gonadotrophin releasing hormone (GnRH) was monitored. Treatment for 4 or 24 h with high concentrations (10(-5) M) of the AE significantly decreased the GnRH-induced LH-release by the gonadotrophs. The negative E2-effect, which is observed in this model after 4 h was enhanced and the positive E2-effect, which occurs after 24 h, was completely reversed into a negative effect by these high AE-concentrations. Treatment of pituitary cells with increasing concentrations of E2 (10(-13)-10(-6) M) or AE (10(-12)-10(-5) M) for 24 h led first to a dose dependent increase of the LH-response to 5 X 10(-10) M GnRH. At higher E2- or AE-concentrations this positive effect was lost, resulting in bell shaped dose-response curves. The following maximal effective concentrations (EDmax) were found: E2 = 10(-10) M, OH-TMX = 10(-9) M, CC = 10(-7) M, TMX = 10(-6) M. Incubation of pituitary cells for 24 h with concentrations of AE near their EDmax and stimulation with increasing concentrations (10(-11)-10(-7) M) of GnRH resulted in significant increases of LH-secretion over a wide range of GnRH-concentrations. It is concluded that AE possess marked intrinsic activities on pituitary LH-secretion: at extremely high concentrations they suppress the GnRH-induced release of the gonadotrophin. At lower concentrations they increase the pituitary LH-response to GnRH in a manner which is qualitatively indistinguishable from that of E2.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516082     DOI: 10.1007/bf02133782

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  20 in total

1.  Sensitisation of pituitary cells to luteinising hormone releasing hormone by clomiphene citrate in vitro.

Authors:  A J Hsueh; G F Erickson; S S Yen
Journal:  Nature       Date:  1978-05-04       Impact factor: 49.962

2.  Modulation of pituitary responsiveness to LRF by estrogen.

Authors:  S S Yen; G Vandenberg; T M Siler
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

3.  Comparison between tamoxifen and clomiphene therapy in women with anovulation.

Authors:  I Gerhard; B Runnebaum
Journal:  Arch Gynecol       Date:  1979

4.  Endocrine profiles in tamoxifen-induced ovulatory cycles.

Authors:  C Tajima; T Fukushima
Journal:  Fertil Steril       Date:  1983-07       Impact factor: 7.329

Review 5.  The neuroendocrine control of the menstrual cycle.

Authors:  E Knobil
Journal:  Recent Prog Horm Res       Date:  1980

Review 6.  Clinical aspects and development of antioestrogen therapy: a review of the endocrine effects of tamoxifen in animals and man.

Authors:  J S Patterson
Journal:  J Endocrinol       Date:  1981       Impact factor: 4.286

7.  High-performance liquid chromatographic determination of clomiphene using post-column on-line photolysis and fluorescence detection.

Authors:  P J Harman; G L Blackman; G Phillipou
Journal:  J Chromatogr       Date:  1981-09-11

8.  Biphasic effects of estrogen on gonadotropin-releasing hormone-induced luteinizing hormone release in monolayer cultures of rat and monkey pituitary cells.

Authors:  L S Frawley; J D Neill
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

9.  Antiestrogens and ovine gonadotrophs: antagonism of estrogen-induced changes in gonadotropin secretions.

Authors:  W L Miller; E S Huang
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

10.  Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture.

Authors:  E S Huang; W L Miller
Journal:  Endocrinology       Date:  1983-02       Impact factor: 4.736

View more
  2 in total

Review 1.  Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment.

Authors:  Fabien Lagarde; Claire Beausoleil; Scott M Belcher; Luc P Belzunces; Claude Emond; Michel Guerbet; Christophe Rousselle
Journal:  Environ Health       Date:  2015-02-11       Impact factor: 5.984

2.  Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study.

Authors:  Yue Lin; Qianqian Chen; Jing Zhu; Yili Teng; Xuefeng Huang; Xia Chen
Journal:  Drug Des Devel Ther       Date:  2021-12-21       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.